Baskhanbio Pharma Inc. (XKON:354390)
South Korea · Delayed Price · Currency is KRW 3,600.00
-140.00 (-3.74%)
At close: Aug 21, 2026
Baskhanbio Pharma Market Cap
Baskhanbio Pharma has a market cap or net worth of 25.27 billion as of August 21, 2026. Its market cap has decreased by -26.15% in one year.
Market Cap
25.27B
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
3,600.00
ChartMarket Cap Chart
Since July 20, 2022, Baskhanbio Pharma's market cap has decreased from 82.82B to 25.27B, a decrease of -69.49%. That is a compound annual growth rate of -25.19%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2026 | 25.27B | -24.69% |
| Dec 30, 2025 | 33.55B | 11.42% |
| Dec 30, 2024 | 30.11B | -36.91% |
| Dec 28, 2023 | 47.72B | 16.64% |
| Dec 29, 2022 | 40.92B | -50.59% |
| Jul 20, 2022 | 82.82B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Korean Drug | 37.16B |
| Korea Arlico Pharm | 36.17B |
| Kyung Nam Pharm | 30.12B |
| HLscience | 28.11B |
| Pharmsville | 27.98B |
| Daesung Microbiological Labs. | 23.45B |
| Seoul Pharma | 23.23B |
| BIFIDO | 22.33B |